Director of Clinical Operations @ Venaxis, Inc (Formerly AspenBio Pharma) (June 2011 - February 2015)
President and Co-Founder @ Eat on the Fly (August 2008 - April 2012)
Sr. Project Manager @ (January 2001 - January 2004)
Director of Research Development @ New England Trial Management Network (August 2000 - February 2001)
Manager of Clinical Operations @ (January 1999 - January 2000)
CRA. Sr. PM @ Pharmaco (January 1992 - January 1999)
Joel Hale Education
Texas State University
US Navy Hospital Corps School
Texas Tech University
Joel Hale Skills
21 CFR Part 11
Asthma
Biotechnology
CRO
CRO Management
CTMS
Cardiology
Clinical Development
Clinical Monitoring
Clinical Operations
Clinical Research
Clinical Support
Clinical Training
Clinical Trial Management
Clinical Trial Management System (CTMS)
Clinical Trials
Dermatology
Drug Development
EDC
Electronic Data Capture (EDC)
Electronic Trial Master File (eTMF)
Executive Management
FDA
Financial Managemnt
GCP
Gastroenterology
Good Clinical Practice (GCP)
Healthcare
ICH-GCP
Infectious Diseases
Leadership
Life Sciences
Lifesciences
Medical Devices
Medidata
Neurology
Oncology
Pediatrics
Pharmaceutical Industry
Pharmaceuticals
Phase I
Problem Solving
Project Management
Project Plans
Protocol
Regulatory Submissions
Request for Proposal (RFP)
Resource Management
Rheumatology
SOP
Site Development
Standard Operating Procedure (SOP)
Study Budgets
Therapeutic Areas
Third-Party Vendor Management
Timeline Management
Trial Management
Urology
Joel Hale Summary
Joel Hale, based in Round Mountain, TX, US, is currently a Vice President, Clinical Operations at Orphai Therapeutics - A Subsidiary of Quince Therapeutics. Joel Hale brings experience from previous roles at Xcelerated Research Corp and WuXi Clinical. Joel Hale holds a Texas State University. With a robust skill set that includes 21 CFR Part 11, Asthma, Biotechnology, CRO, CRO Management and more. Joel Hale has 2 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Joel Hale?
Find contact details for 700 million professionals.